CorMedix Inc. 8-K

What Happened

• CorMedix Inc. (CRMD) filed a Form 8-K (Item 2.02) on May 14, 2026, to announce its quarterly results: the company issued a press release reporting financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the filing. The 8-K was signed by Joseph Todisco, Chief Executive Officer.

Key Details

• Filing date: May 14, 2026 (Form 8-K).
• Reporting period: quarter ended March 31, 2026 (Q1 2026).
• Disclosure: press release announcing results furnished as Exhibit 99.1.
• Signature: 8-K signed by Joseph Todisco, CEO of CorMedix.

Why It Matters

• Quarterly results and management commentary can affect the company’s stock price and investor outlook; this filing indicates CorMedix has publicly released its Q1 2026 earnings information.
• Retail investors should review the linked press release (Exhibit 99.1) for details on revenue, net income/loss, cash position, and any forward guidance or operational updates that will inform valuation and near-term expectations.